Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Calcium supplements linked to reduced renal cell carcinoma risk in postmenopausal women.

This article was originally published in The Tan Sheet

Executive Summary

CALCIUM SUPPLEMENT USE LINKED TO REDUCED RENAL CELL CARCINOMA RISK in a study involving 35,192 postmenopausal women published in the January issue of Epidemiology. "Total dietary calcium (relative risks=.48 and .66 for the 2nd and 3rd tertiles) and calcium supplement use (RR=.52) were inversely associated with risk of renal cell carcinoma," Ronald Prineas et al. concluded. Prineas is with the University of Miami; the other researchers are with the University of Minnesota and the Fred Hutchinson Cancer Research Center in Seattle. The study was funded in part by a grant from the National Cancer Institute.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086713

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel